Specific immunotherapy with allergen mixes: what is the evidence?
about
Changes in skin reactivity and associated factors in patients sensitized to house dust mites after 1 year of allergen-specific immunotherapy.Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoA WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics.The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.Multiallergen-specific immunotherapy in polysensitized patients: where are we?Effect on quality of life of the mixed house dust mite/weed pollen extract immunotherapy.
P2860
Specific immunotherapy with allergen mixes: what is the evidence?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Specific immunotherapy with allergen mixes: what is the evidence?
@en
Specific immunotherapy with allergen mixes: what is the evidence?
@nl
type
label
Specific immunotherapy with allergen mixes: what is the evidence?
@en
Specific immunotherapy with allergen mixes: what is the evidence?
@nl
prefLabel
Specific immunotherapy with allergen mixes: what is the evidence?
@en
Specific immunotherapy with allergen mixes: what is the evidence?
@nl
P1476
Specific immunotherapy with allergen mixes: what is the evidence?
@en
P2093
Harold S Nelson
P304
P356
10.1097/ACI.0B013E328330EE69
P577
2009-12-01T00:00:00Z